ClinicalTrials.Veeva

Menu

Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft Surgery

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Coronary Artery Disease

Treatments

Procedure: CABG surgery

Study type

Observational

Funder types

Other

Identifiers

NCT02410993
4-2015-0063

Details and patient eligibility

About

According to 2011 ACCF/AHA guideline and 2014 ESC/EACTS guideline, CABG surgery was recommended for three-vessel coronary artery disease and left main coronary artery disease in the patients with stable ischemic heart disease as class I. 2-VD with proximal left anterior descending artery stenosis was also indicated for CABG surgery as class I recommendation. However, many patients have been recommended for PCI by catheterization laboratory cardiologist; 46% and 93% in the only-CABG candidates and both CABG and PCI candidates, retrospectively, defined by previous ACC/AHA guideline. Although the discordance between real practice in catheterization laboratory and guideline would be adjusted by recently updated guideline. The revascularization strategy for patients with 3-VD/LMD in real practice have been getting toward more PCI and less CABG surgery. In this study, we will identify the rate of CABG candidates who were treated with PCI or medical treatment instead of CABG surgery in different from current guideline. We are also going to compare two treatment strategies CABG surgery vs. PCI with 2nd generation DES regarding clinical outcomes.

Enrollment

2,500 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥ 19 years old
  • Left main disease, three-vessel disease or two-vessel disease with proximal LAD stenosis.

Exclusion criteria

  • Previous PCI within 1 year
  • Previous sternotomy
  • Primary PCI for STEMI
  • Contraindication or hypersensitivity to anti-platelet medications or contrast media
  • Planned need for concomitant other cardiac surgery (eg, valve surgery or resection of aortic or left ventricular aneurysm, etc)
  • Pregnant women or women with potential childbearing
  • Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  • Inability to understand or read the informed content

Trial design

2,500 participants in 1 patient group

CABG surgery
Description:
Candidates for CABG surgery for left main disease, three-vessel disease or two-vessel disease with proximal LAD stenosis indicated by current practice guideline
Treatment:
Procedure: CABG surgery

Trial contacts and locations

1

Loading...

Central trial contact

Myeong Ki Hong, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems